X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (475) 475
Publication (63) 63
Book Review (5) 5
Book / eBook (2) 2
Conference Proceeding (2) 2
Book Chapter (1) 1
Report (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (306) 306
female (269) 269
index medicus (232) 232
breast cancer (187) 187
oncology (183) 183
middle aged (165) 165
adult (137) 137
cancer (122) 122
breast neoplasms - pathology (121) 121
aged (117) 117
surgery (75) 75
prognosis (68) 68
breast neoplasms - surgery (65) 65
women (65) 65
breast neoplasms - drug therapy (61) 61
medicine & public health (59) 59
chemotherapy (56) 56
mammography (56) 56
breast neoplasms - diagnosis (52) 52
research (52) 52
neoplasm staging (51) 51
breast neoplasms - therapy (50) 50
care and treatment (50) 50
article (49) 49
breast neoplasms - genetics (48) 48
diagnosis (45) 45
abridged index medicus (43) 43
risk (42) 42
neoadjuvant therapy (41) 41
survival (41) 41
health aspects (40) 40
treatment outcome (40) 40
tumors (40) 40
magnetic resonance imaging (39) 39
breast neoplasms - mortality (37) 37
retrospective studies (37) 37
breast-cancer (36) 36
aged, 80 and over (35) 35
prospective studies (35) 35
mastectomy (34) 34
male (33) 33
breast neoplasms - metabolism (32) 32
recurrence (32) 32
neoadjuvant chemotherapy (31) 31
analysis (30) 30
chemotherapy, adjuvant (30) 30
medicine, general & internal (30) 30
risk factors (30) 30
therapy (29) 29
usage (29) 29
biopsy (28) 28
follow-up studies (28) 28
carcinoma (27) 27
risk assessment (27) 27
breast (26) 26
patients (26) 26
biomarkers (25) 25
breast neoplasms - prevention & control (25) 25
predictive value of tests (25) 25
prevention (25) 25
radiology, nuclear medicine & medical imaging (25) 25
research article (25) 25
breast neoplasms - epidemiology (24) 24
genetic aspects (24) 24
clinical trials (23) 23
surgical oncology (23) 23
time factors (23) 23
adjuvant treatment (22) 22
hematology, oncology and palliative medicine (22) 22
sensitivity and specificity (22) 22
antineoplastic combined chemotherapy protocols - therapeutic use (21) 21
tamoxifen (21) 21
breast neoplasms - diagnostic imaging (20) 20
gene expression (20) 20
mastectomy, segmental (20) 20
mortality (20) 20
cancer therapies (19) 19
epidemiology (19) 19
neoplasm invasiveness (19) 19
radiotherapy (19) 19
receptors, estrogen - metabolism (19) 19
carcinoma in-situ (18) 18
survival analysis (18) 18
animals (17) 17
breast neoplasms - radiotherapy (17) 17
medicine (17) 17
neoplasms. tumors. oncology. including cancer and carcinogens (17) 17
oncology, experimental (17) 17
trial (17) 17
cancer patients (16) 16
endocrine therapy (16) 16
metastasis (16) 16
studies (16) 16
surgical adjuvant breast (16) 16
decision making (15) 15
disease-free survival (15) 15
early detection of cancer (15) 15
expression (15) 15
follow-up (15) 15
mammaplasty (15) 15
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


BMJ (Online), ISSN 0959-8146, 01/2019, Volume 364, p. k4699
Journal Article
Nature Reviews Clinical Oncology, ISSN 1759-4774, 11/2018, Volume 15, Issue 11, pp. 661 - 662
Population-based mammographic screening is widely accepted as an intervention to reduce overall mortality from breast cancer, but at the cost of morbidity due... 
BREAST-CANCER | ONCOLOGY | Mass Screening | Breast Neoplasms | Early Detection of Cancer | Cost-Benefit Analysis | Humans | Care and treatment | Molecular diagnostic techniques | Innovations | Breast cancer | Genetic aspects | Diagnosis | Cost benefit analysis | Clinical trials | Mammography | Risk groups | Medical screening | Morbidity
Journal Article
JAMA, ISSN 0098-7484, 08/2013, Volume 310, Issue 8, pp. 797 - 798
Esserman et al point out that the original intent of screening was to detect cancer at the earliest stages to improve outcomes; however, detection of cancers... 
BREAST-CANCER | MORTALITY | MEDICINE, GENERAL & INTERNAL | United States - epidemiology | Neoplasms - therapy | Prognosis | Diagnostic Errors | Early Detection of Cancer | Humans | Terminology as Topic | Registries | Unnecessary Procedures | Neoplasms - diagnosis | Neoplasms - epidemiology | Medical screening | Medical diagnosis | Medical treatment | Clinical outcomes | Cancer
Journal Article
Nature Reviews Clinical Oncology, ISSN 1759-4774, 12/2013, Volume 10, Issue 12, pp. 673 - 675
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 2/2012, Volume 109, Issue 8, pp. 2796 - 2801
Retrospective clinical studies have used immune-based biomarkers, alone or in combination, to predict survival outcomes for women with breast cancer (BC);... 
T lymphocytes | Cytometry | Lymphocytes | Breasts | BREAST CANCER SPECIAL FEATURE | Residual neoplasm | Breast cancer | Leukocytes | Macrophages | Tumors | Cancer | Inflammation | Macrophage | INFILTRATING LYMPHOCYTES | MULTIDISCIPLINARY SCIENCES | VEGF EXPRESSION | macrophage | MICROVESSEL DENSITY | MAMMARY-TUMORS | inflammation | MOUSE MODEL | REGULATORY T-CELLS | TUMOR-ASSOCIATED MACROPHAGES | CARCINOMA | PROGRESSION | ENDOTHELIAL GROWTH-FACTOR | Neoplasm, Residual - pathology | Leukocytes - pathology | Breast Neoplasms - immunology | Humans | Antineoplastic Agents - therapeutic use | Cell Lineage - drug effects | Antigens, CD - metabolism | Leukocytes - immunology | Lymphocyte Activation - immunology | Myeloid Cells - immunology | T-Lymphocytes - drug effects | Biomarkers, Tumor - metabolism | Female | Myeloid Cells - drug effects | Neoadjuvant Therapy | Neoplasm, Residual - immunology | Antineoplastic Agents - pharmacology | T-Lymphocytes - pathology | Cytotoxicity, Immunologic - drug effects | Lymphocytes, Tumor-Infiltrating - drug effects | Breast Neoplasms - drug therapy | Cell Movement - drug effects | Phenotype | Lymphocytes, Tumor-Infiltrating - pathology | Breast Neoplasms - pathology | Lymphocyte Activation - drug effects | Antigens, Differentiation, Myelomonocytic - metabolism | Leukocytes - drug effects | T-Lymphocytes - immunology | Myeloid Cells - pathology | Lymphocytes, Tumor-Infiltrating - immunology | Physiological aspects | Development and progression | Health aspects | Biological Sciences
Journal Article
NPJ breast cancer, ISSN 2374-4677, 2019, Volume 5, Issue 1, pp. 12 - 6
Dedicated breast positron emission tomography (dbPET) is an emerging technology with high sensitivity and spatial resolution that enables detection of... 
Medical research | Nuclear magnetic resonance--NMR | Medical imaging | Disease | Feasibility studies | Metadata | Endocrine therapy | Breast cancer | Patients | Cancer therapies | Chemotherapy | Ultrasonic imaging | Biopsy | Tomography | Clinical medicine | Tumors
Journal Article
NPJ breast cancer, ISSN 2374-4677, 2019, Volume 5, Issue 1, pp. 17 - 5
Pexidartinib (PLX3397) is a small molecule tyrosine kinase and colony-stimulating factor-1 inhibitor with FDA breakthrough therapy designation for tenosynovial... 
Medical research | Edema | Medical imaging | Liver | Breast cancer | Family medical history | Patients | Cancer therapies | Abdomen | Studies | Chemotherapy | Gallbladder | Lymphomas | Drug dosages | Bile | Tumors
Journal Article
npj Breast Cancer, ISSN 2374-4677, 12/2018, Volume 4, Issue 1, pp. 31 - 11
Detection of disseminated tumor cells (DTCs) in bone marrow is an established negative prognostic factor. We isolated small pools of (~20) EPCAM-positive DTCs... 
Bone marrow | Breast cancer | Gene expression | Tumors
Journal Article
Journal Article
Journal Article
Breast Cancer Research and Treatment, ISSN 0167-6806, 4/2012, Volume 132, Issue 3, pp. 1049 - 1062
Journal Article